Avaliação econômica das associações fixas de prostaglandina/prostamida e timolol no tratamento do glaucoma e da hipertensão ocular
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
-
Abstract
PURPOSE:To assess the 5-year cost, effectiveness and costeffectiveness of fixed combinations of prostaglandin or prostamide and timolol 0. 5% on glaucoma and/or ocular hypertension in the state of Minas Gerais, Brazil.
METHODS: This cross-sectional study evaluated the following fixed combinations: bimatoprost/timolol 0. 5% (BT), latanoprost/timolol 0. 5% (LT) and travoprost/ timolol 0. 5% (TT). Cost was obtained through mean number of drops in a sample of 5 containers of each medication, duration (days) and the average wholesale price (AWP). Effectiveness in reducing intraocular pressure IOP was derived from the literature. Daily, monthly, annually and 5-year cost was calculated. Costeffectiveness was defined as cost by each percentage of IOP reduction over 5 years.
RESULTS: AWP, mean number of drops and mean duration (days) were: R$ 83. 07; 109. 4 and 54. 7 for BT; R$ 126. 03; 97. 0 and 48. 5 for LT and R$ 97. 47; 96. 0 and 48. 0 for TT. Mean percentage of IOP reduction, obtained from literature, was: 35. 10% for BT, 35. 00% for LT and 34. 70% for TT. Cost-effetiveness ratio (R$/%) was: 61. 02 for BT, 104. 71 for LT and 82. 53 for TT. BT was dominant over LT and TT.
CONCLUSION: BT presented lower costs and better effectiveness when compared to LT and TT. The most cost-effective fixed combination was BT.
Description
Keywords
Glaucoma/economia , Glaucoma/quimioterapia , Pressão intraocular/economia , Pressão intraocular/quimioterapia , Anti-hipertensivos/economia , Antihipertensivos/administração & dosagem , Timolol/administração & dosagem , Timolol/economia , Prostaglandinas F sintéticas/administração & dosagem , Prostaglandinas F sintéticas/economia , Combinação de medicamentos , Análise custo-efetividade , Glaucoma/economics , Glaucoma/drug therapy , Intraocular pressure/economics , Intraocular pressure/drug therapy , Antihypertensive agents/ administration & dosage Antihypertensive agents/economics , Timolol/administration & dosage , Timolol/economics , Prostaglandins F, Synthetic/administration & dosage , Prostaglandins F, synthetic/economics , Drug combinations , Cost-effectiveness analysis
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
